Free press releases distribution network?

Agency / Source: General Electric Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



GE Healthcare Collaborates on Investigational Molecular Breast Imaging System for Early Breast Cancer Detection - Investigational MBI system in clinical trials at two major cancer research centers outside the U.S.* (NYSE: GE)
GE Healthcare Collaborates on Investigational Molecular Breast Imaging System for Early Breast Cancer Detection

 

PRZOOM - /newswire/ - Salt Lake City, UT, United States, 2010/06/07 - Investigational MBI system in clinical trials at two major cancer research centers outside the U.S.* (NYSE: GE). NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

GE Healthcare, a unit of General Electric Company (NYSE: GE), announced its collaboration in two clinical trials with the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel and Hamilton Health Sciences Hospital in Ontario, Canada on the use of a novel technology that may assist in assessment and early detection of breast cancer in women who are at high risk for the disease.

GE Healthcare’s investigational Molecular Breast Imaging (MBI) system is a gamma camera dedicated for breast imaging based on accumulation of a radioactive tracer in hypermetabolic cancer cells. The innovation of the MBI technology is the use of imaging detectors, Cadmium Zinc Telluride (CZT), to replace the standard NaI detectors routinely used for gamma cameras, in a dedicated breast device. Extensive early clinical work done in the Mayo Clinic in the U.S. shows encouraging results with the use of MBI technology.

In these two prospective studies, the diagnostic accuracy of MBI will be determined in patients at high risk for breast cancer, including patients with dense breast tissue in whom conventional modalities used for breast, X-ray mammography and ultrasonography, are suboptimal.

“Breast cancer is a foremost health problem for women worldwide and it is growing in numbers,” said Nathan Hermony, GE Healthcare Nuclear Medicine global manager. “Early detection is critical for improving breast cancer survival rates. This technology is intended to improve early detection in women who are at high risk for developing breast cancer, or in women with dense breasts who are less likely to benefit from conventional mammography.”

Several medical research centers showed great interest in receiving the first GE Healthcare MBI systems for clinical trials. Two centers, outside the U.S. were selected; Hamilton Health Sciences Hospital in Ontario, Canada, and Tel Aviv’s Sourasky Medical Center, Israel. Both centers have started the evaluation.

Hamilton Health Sciences (HHS) was selected for the clinical trials based on the strength of its internationally recognized breast cancer research, and expertise in nuclear medicine. HHS also benefits from solid, collaborative partnerships with the Ontario Clinical Oncology Group (OCOG), the Ontario Institute for Cancer Research (OICR) and the Centre for Probe Development and Commercialization (CPDC), a new world-class organization focused on the development and commercialization of molecular imaging probes and related technologies.

The team in Hamilton is running a Prospective Pilot Study to explore the ability of the GE Healthcare MBI system to detect breast cancer, and to evaluate the feasibility, acceptability, and safety of using a MBI Gamma camera in women at high risk of developing breast cancer. Dr Mark Levine, Dr. Karen Gulenchyn and Dr. John Valliant developed the project for the trial.

The Institute of Nuclear Medicine in the Tel Aviv Souraskiy Medical Center (tasmc.org.il/e/272) is running a clinical trial for early detection of breast cancer in women where current imaging techniques, mainly mammography, are less effective. The trial is headed by Einat Even-Sapir, MD, PhD, Head of the Institute for Nuclear Medicine with Dr. Hedva Lerman as a principle investigator The purpose of the study is to assess the clinical performance of the new technology specifically in areas where current clinical techniques are not optimal: women with dense breast tissue, after previous surgery and women with locally advanced breast cancer Before and after neo-adjuvant chemotherapy.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $16 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare (gehealthcare.com) employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

*The GE MBI camera is an investigational device limited by U.S. and Canadian law to investigational use.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


GE Healthcare Collaborates on Investigational Molecular Breast Imaging System for Early Breast Cancer Detection

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
GE News Center |
Contact: Rebecca Hayne - GE Healthcare 
+1 414-721-3871 Rebecca.hayne[.]ge.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From General Electric Company / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

ZOLL Canada Wins Tender to Equip Province of Québec Paramedic Services with ZOLL X Series Monitor/Defibrillators
Top Speakers, Brands Commit to SCBIO 2017 - SC Governor McMaster to Keynote Life Sciences Conference
Frost & Sullivan Recognizes Acelity as a Leader in the Field with its New V.A.C.ULTA™ 4 Therapy System and V.A.C. VERAFLO CLEANSE CHOICE™ Dressing
Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  SKS Media | SKS Associates Ltd

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today